EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

NCT04509674 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6522

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]